• Hope for ALS sufferers

    ALS patients are routinely told there is no treatment
    available to them until new drugs are approved.
    For many who measure their lifetimes in months,
    that’s just not good enough.



    read more
  • Treatment Access for TODAY’S ALS Patients

    We don’t just WANT earlier treatment access.
    We are leading the work to make it a reality
    for patients who cannot wait.



    read more

  • Partnership

    We bring the funding and the in-house expertise required to
    conduct expanded access treatment programs (EAP),
    in partnership with commercial drug sponsors and ALS clinics.
    The Result: Earlier treatment options for more ALS patients.



    read more

The ALS Emergency Treatment Fund was launched in 2012 to sponsor medically appropriate
treatment programs for investigational ALS drugs.  The goal is to provide current dying patients
with immediate access to potentially life-extending drugs while those drugs continue the long
process toward standard marketing approval.

Our Partners

Our Partners

Research Clinics

Research Clinics

Our Calendar

Our Calendar

We Are You

We Are You

Twitter Central

ALS-ETF partners with Denovo Biomarkers to leverage treatment access programs. genengnews.com/gen-news-highl… #ALS #BIOMARKERS

About 2 weeks ago · reply · retweet · favorite